BSMA Award

The BSMA Award for Supply Chain Management Innovation will be given to the chosen entity from stakeholders of the Biotech industry – Manufacturers, Service Providers, Material Suppliers, Technology Enablers, Academia, Management Consultants, Trade Associations and Governmental Regulators, as approved by the Advisory Board of BSMA.  A winner will be adjudged from all stakeholders as deemed meeting standards of excellence by the review committee.

Application Deadline: August 31, 2020

Submit an entry for this prestigious award to (click on name below):

Devendra Mishra, 818-224-1552

Showcase your innovative project!

Submit a 300-word Case Study to include the nature of the innovation that enhanced the supply chain; objective(s) of the endeavor; strategies and tactics adopted; benefits realized and costs incurred; human, technology and organizational resources deployed; and, governmental compliance requirements met, if applicable.  Please identify the Company to be recognized for the award.

Winners will be selected by a prestigious panel of judges and honored at BSMA’s Annual Conference on October 22, 2020 at the Crowne Plaza Suites, Foster City, CA.  Dr. Phil Kaminski, Chairman, Department of IE & OR, UC Berkeley, will be the Chairman of the Awards Committee.

BSMA SCM Innovation Award Winners will receive:

• Recognition at the BSMA 13th Annual Conference
• A prestigious iconic award
• Two complimentary full conference passes to BSMA’s 13th Annual Conference, and Networking opportunity with executives and other award-winning colleagues
• Your innovation story featured in the BSMA press releases and posted on the BSMA website
• Opportunity for an interview to be published by BSMA

BACKGROUND FOR THE AWARD

This award recognizes that increasing pace of innovation, regulatory issues, and overall distribution complexities of the industry produce extraordinary supply chain opportunities. Integration of supply chain management with R&D and sales & marketing organizations is the key to fully capturing business opportunities, increasing speed-to-market, and reducing costs. Product introduction is accelerating and there is an increasing level of interest in ways that all parties can work together to optimize the supply chain to support and sustain market demands. Efforts to overcome counterfeiting, potential recalls and patent-expiration as drugs progress through their life-cycle is improving patient safety. Furthermore, collaboration in the end-to-end supply chain of the biotech industry is the key for Jay Forrester’s stated objective to “minimize system-wide cost for supply chain management optimization” to be realized. Consequently, recognizing innovation is deemed critical for the growth of biotech.